Page last updated: 2024-11-05

trifluoperazine and Nasopharyngeal Neoplasms

trifluoperazine has been researched along with Nasopharyngeal Neoplasms in 1 studies

Nasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.

Research Excerpts

ExcerptRelevanceReference
"Trifluoperazine (TFP) is a typical antipsychotic primarily used to treat schizophrenia."5.91Antipsychotic drug trifluoperazine as a potential therapeutic agent against nasopharyngeal carcinoma. ( Hsu, YB; Lan, MC; Lan, MY; Lee, WY; Yeh, CF; Yu, TH, 2023)
"Trifluoperazine (TFP) is a typical antipsychotic primarily used to treat schizophrenia."1.91Antipsychotic drug trifluoperazine as a potential therapeutic agent against nasopharyngeal carcinoma. ( Hsu, YB; Lan, MC; Lan, MY; Lee, WY; Yeh, CF; Yu, TH, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yeh, CF1
Lee, WY1
Yu, TH1
Hsu, YB1
Lan, MC1
Lan, MY1

Other Studies

1 other study available for trifluoperazine and Nasopharyngeal Neoplasms

ArticleYear
Antipsychotic drug trifluoperazine as a potential therapeutic agent against nasopharyngeal carcinoma.
    Head & neck, 2023, Volume: 45, Issue:2

    Topics: Animals; Antipsychotic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Nasopharyngeal C

2023